Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Enteric Bioelectronics for Sensing and Stimulating the CNS

Project description

Bioelectronic tools explore ENS control of the CNS

Treatments for neurological disorders often involve invasive procedures, but the connection between gastrointestinal (GI) disorders and neurological conditions is frequently overlooked. The enteric nervous system (ENS) plays a role in influencing brain activity, demonstrating a bidirectional relationship between gut health and neurological conditions such as epilepsy, Alzheimer’s, and Parkinson’s. The EIC-funded EnterBio project will adapt bioelectronic tools, previously used in the central nervous system (CNS), for sensing and stimulating the ENS, thus influencing the CNS. The project will develop bioelectronic sensors, stimulation electrodes, and drug delivery systems designed to interface with the ENS through implantation in the gut. By using high-resolution sensing signals in vivo, the project will explore how the ENS controls the CNS and aims to identify non-invasive therapies for CNS disorders.

Objective

Therapies for neurological disorders often involve deeply invasive brain operations or implants. A largely overlooked aspect of these conditions is the high comorbidity of GI-related disorders. Although the top-down relationship between the brain and peripheral organs has dominated the field, it’s now clear that activity of peripheral organs, in particular GI innervation – the enteric nervous system (ENS) – not only influences brain activity, but also paces and regulates it. Indeed, recent studies have shown the bidirectional relationship between gut homeostasis and neurological function in disorders such as epilepsy, Alzheimer’s, and Parkinson’s.

EnterBio will adapt bioelectronic tools developed over the past decades for application in the CNS for sensing and stimulating the ENS, and thereby sensing and stimulating the CNS. The team comprises world-leading expertise in organic and graphene bioelectronics, drug delivery, in vitro/animal models of neurodegenerative disorders, and molecular/ cellular physiology of the PNS. We propose to turn this expertise toward the ENS to develop a platform for elucidation, prediction, and control of CNS function. Objectives are to:

– Develop bioelectronic sensors, stim. electrodes, and drug deliv. targeting ENS and adapted for implantation in the gut

– Elucidate ENS control of CNS using high-res sensing signals in vivo

– Demonstrate control & eventual therapy for CNS disorders without highly invasive implants

EnterBio proposes to build on new, cutting-edge directions (organic/carbon-based bioelectronics and the gut-brain axis) to disrupt the field of CNS sensing/neuromodulation as technology to utilize ENS activity as an entry point to brain (dys)function is lacking. “Entering the bio” through the gut will be exactly this disruptor. EnterBio will achieve substantial improvements in relation to the barriers and obstacles of today’s sensing/neuromodulation technologies.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2023-PATHFINDEROPEN-01

See all projects funded under this call

Coordinator

LINKOPINGS UNIVERSITET
Net EU contribution
€ 1 333 300,00
Address
CAMPUS VALLA
581 83 Linkoping
Sweden
Region
Östra Sverige Östra Mellansverige Östergötlands län
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 333 300,25

Participants (5)

Partners (1)